Search
for

    Sort by

    Research 121–150 of 1000+

    1. Alopecias in humans: biology, pathomechanisms and emerging therapies Veterinary dermatology · 2021 · 3 citations
    2. Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology) Actas Dermo-Sifiliográficas · 2026
    3. Revisión y avances en tricología Medicine - Programa de Formación Médica Continuada Acreditado · 2025
    4. Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata JEADV Clinical Practice · 2023
    5. Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib Anais Brasileiros de Dermatologia · 2026
    6. Novel potential therapeutic targets of alopecia areata Frontiers in Immunology · 2023 · 1 citations
    7. Skin cancer risk in alopecia areata: a systematic review and meta-analysis Frontiers in Oncology · 2026
    8. New and Emerging Therapies for Alopecia Areata Drugs · 2020 · 46 citations
    9. Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata Inflammatory Bowel Diseases · 2021 · 5 citations
    10. Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata PNAS nexus · 2022 · 2 citations
    11. Delayed granulomatous eruption of the nose associated with ruxolitinib JAAD case reports · 2020 · 2 citations
    12. Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata Expert Review of Clinical Immunology · 2026
    13. A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata. PubMed · 2025
    14. Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases Meditsinskiy sovet = Medical Council · 2025
    15. Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review Expert Opinion on Drug Metabolism & Toxicology · 2025
    16. Free Papers Medical and Surgical: Hair and Nails Australasian Journal of Dermatology · 2019
    17. Registrars and Fellows Update Session 2 Australasian Journal of Dermatology · 2017
    18. Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata British Journal of Dermatology · 2019 · 5 citations
    19. Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data BMJ Open · 2025 · 2 citations
    20. Advances in Vitiligo Treatment International Journal of Dermatology Venereology and Leprosy Sciences · 2026
    21. Vitiligo Pigment International · 2024
    22. Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study Dermatology and therapy · 2024
    23. Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease Blood · 2018 · 33 citations
    24. Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review International Journal of Molecular Sciences · 2025
    25. 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias Journal of Investigative Dermatology · 2017 · 1 citations
    26. JAK inhibitors and alopecia areata Lancet · 2019 · 56 citations
    27. Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis Frontiers in Pharmacology · 2025 · 3 citations
    28. The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article Saudi Medical Horizons Journal · 2026
    29. Treatment of alopecia areata with JAK inhibitors: a review of the literature Acta Dermatovenerologica Alpina Pannonica et Adriatica · 2025
    30. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations